A metastable polymorph of metformin hydrochloride: Isolation and characterization using capillary crystallization and thermal microscopy techniques

被引:77
作者
Childs, SL
Chyall, LJ
Dunlap, JT
Coates, DA
Stahly, BC
Stahly, GP
机构
[1] Design Sci Res LLC, Atlanta, GA 30306 USA
[2] SSCI Inc, W Lafayette, IN 47906 USA
关键词
D O I
10.1021/cg034243p
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Capillary crystallization techniques and thermal microscopy have been used to identify and characterize a metastable polymorph of metformin hydrochloride. The single crystal structure of the metastable polymorph (Form B) is reported and compared to the known thermodynamically stable form (Form A). There is a 5.8% density difference between Form A and Form B. N-H...N hydrogen bonds form a ID rod motif in Form A as opposed to a OD dimer in Form B, while the charge-assisted N-H...Cl hydrogen bonds maintain a layered motif in both Forms A and B. The preferential generation of metastable solid phases is discussed in the context of classical nucleation theory.
引用
收藏
页码:441 / 449
页数:9
相关论文
共 39 条
[1]   Physico-chemical characterisation of the modifications I and II of (R,S) propranolol hydrochloride: solubility and dissolution studies [J].
Bartolomei, M ;
Bertocchi, P ;
Ramusino, MC ;
Santucci, N ;
Valvo, L .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (02) :299-309
[2]  
Bernstein J, 1999, ANGEW CHEM INT EDIT, V38, P3440, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO
[3]  
2-#
[4]  
Bernstein J., 2020, Polymorphism in Molecular Crystals, Vsecond
[5]   Crystallization of biological macromolecules using agarose gel [J].
Biertümpfel, C ;
Basquin, J ;
Suck, D ;
Sauter, C .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1657-1659
[6]  
Bretnall AE, 1998, ANAL PROF DRUG SUBST, V25, P243, DOI 10.1016/S0099-5428(08)60757-1
[7]  
*BRUK AXS INC, 2000, SEHLXTL V5 10
[8]  
*BRUK AXS INC, 2000, SMART VERS 5 624
[9]  
*BRUK AXS INC, 2000, SAINT VERS 6 02
[10]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417